» Articles » PMID: 37798095

Understanding the Pathophysiology of Idiopathic Intracranial Hypertension (IIH): a Review of Recent Developments

Overview
Date 2023 Oct 5
PMID 37798095
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with headaches, visual abnormalities, tinnitus and cognitive dysfunction. Raised intracranial pressure without a secondary identified cause remains a key diagnostic feature of this condition, however, the underlying pathophysiological mechanisms that drive this increase are poorly understood. Previous theories have focused on cerebrospinal fluid (CSF) hypersecretion or impaired reabsorption, however, the recent characterisation of the glymphatic system in many other neurological conditions necessitates a re-evaluation of these hypotheses. Further, the impact of metabolic dysfunction and hormonal dysregulation in this population group must also be considered. Given the emerging evidence, it is likely that IIH is triggered by the interaction of multiple aetiological factors that ultimately results in the disruption of CSF dynamics. This review aims to provide a comprehensive update on the current theories regarding the pathogenesis of IIH.

Citing Articles

Outcomes of Stenting in Atypical Idiopathic Intracranial Hypertension Patients With Transverse Sinus Stenosis.

Song S, Guan Z, Wang S, Gan Y, Chen F, He J Brain Behav. 2025; 15(2):e70351.

PMID: 39972974 PMC: 11839763. DOI: 10.1002/brb3.70351.


Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.

Azzam A, Essibayi M, Farkas N, Azab M, Morsy M, Elamin O Endocrinol Diabetes Metab. 2025; 8(2):e70019.

PMID: 39949069 PMC: 11825589. DOI: 10.1002/edm2.70019.


Stenting versus medical treatment for idiopathic intracranial hypertension based on a propensity score matching method.

Xu Z, Xu Y, Xu Y, Zhang S, Wu Y, Zhu M Quant Imaging Med Surg. 2025; 15(1):524-536.

PMID: 39839059 PMC: 11744137. DOI: 10.21037/qims-24-1417.


The Impact of Idiopathic Intracranial Hypertension on Cardiovascular Disease Risk Among UK Women: An Obesity-Adjusted Analysis.

Azzam A, Morsy M, Ellabban M, Morsy A, Zahran A, Nassar M ASIDE Intern Med. 2025; 1(1):1-11.

PMID: 39830613 PMC: 11739732. DOI: 10.71079/h1fr8h68.


Antithrombin III deficiency and idiopathic intracranial hypertension: a case report.

Togha M, Mokary Y, Jafari E J Med Case Rep. 2025; 19(1):2.

PMID: 39755655 PMC: 11700454. DOI: 10.1186/s13256-024-04997-z.